Actively Recruiting
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Led by Nanjing IASO Biotechnology Co., Ltd. · Updated on 2025-06-19
1500
Participants Needed
6
Research Sites
989 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, open-label, single-arm, long-term follow-up clinical study. All patients who have received Equecabtagene Autoleucel Injection treatment will be enrolled.
CONDITIONS
Official Title
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received Equecabtagene Autoleucel Injection treatment
- Participated in pre-marketing clinical studies or post-marketing real-world studies and have completed or withdrawn from the original study
- Voluntarily signed an informed consent form approved by the ethics committee
You will not qualify if you...
- Received another lentiviral vector-based cell or gene therapy between the infusion of Equecabtagene Autoleucel Injection and signing informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Peking University First Hospital
Beijing, China
Not Yet Recruiting
2
People's Hospital of Peking Universit
Beijing, China
Not Yet Recruiting
3
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Actively Recruiting
4
Tianjin Medical University General Hospital
Tianjin, China
Actively Recruiting
5
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Not Yet Recruiting
6
Henan Cancer Hospital Affilated Cancer Hospital of Zhengzhou University
Zhengzhou, China
Not Yet Recruiting
Research Team
W
Wen Ye
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here